| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers.
|
PLoS One
|
2008
|
4.60
|
|
2
|
Epidemiology of invasive mycoses in North America.
|
Crit Rev Microbiol
|
2010
|
4.06
|
|
3
|
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
|
J Antimicrob Chemother
|
2009
|
3.82
|
|
4
|
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.
|
J Clin Microbiol
|
2007
|
3.51
|
|
5
|
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
|
Clin Infect Dis
|
2004
|
3.20
|
|
6
|
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management.
|
J Clin Microbiol
|
2003
|
3.17
|
|
7
|
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
|
J Clin Microbiol
|
2005
|
2.26
|
|
8
|
Adverse outcomes associated with Contact Precautions: a review of the literature.
|
Am J Infect Control
|
2009
|
2.21
|
|
9
|
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
|
Antimicrob Agents Chemother
|
2010
|
2.03
|
|
10
|
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.
|
Antimicrob Agents Chemother
|
2011
|
2.01
|
|
11
|
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units.
|
J Infect Dis
|
2006
|
1.97
|
|
12
|
A multicenter intervention to prevent catheter-associated bloodstream infections.
|
Infect Control Hosp Epidemiol
|
2006
|
1.93
|
|
13
|
Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).
|
Emerg Infect Dis
|
2013
|
1.84
|
|
14
|
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
|
Diagn Microbiol Infect Dis
|
2007
|
1.80
|
|
15
|
Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.
|
Infect Control Hosp Epidemiol
|
2005
|
1.78
|
|
16
|
Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
|
J Clin Microbiol
|
2003
|
1.75
|
|
17
|
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.
|
J Clin Microbiol
|
2008
|
1.66
|
|
18
|
Enhanced identification of postoperative infections among inpatients.
|
Emerg Infect Dis
|
2004
|
1.56
|
|
19
|
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.
|
J Clin Microbiol
|
2012
|
1.47
|
|
20
|
Clinical significance of positive cranial bone flap cultures and associated risk of surgical site infection after craniotomies or craniectomies.
|
J Neurosurg
|
2011
|
1.45
|
|
21
|
Improving the assessment of vancomycin-resistant enterococci by routine screening.
|
J Infect Dis
|
2006
|
1.44
|
|
22
|
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
|
Diagn Microbiol Infect Dis
|
2011
|
1.42
|
|
23
|
Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections.
|
J Clin Microbiol
|
2007
|
1.42
|
|
24
|
Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants.
|
Infect Control Hosp Epidemiol
|
2010
|
1.40
|
|
25
|
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
|
Antimicrob Agents Chemother
|
2011
|
1.38
|
|
26
|
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.
|
Antimicrob Agents Chemother
|
2013
|
1.29
|
|
27
|
Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.
|
J Clin Microbiol
|
2011
|
1.29
|
|
28
|
Preventing MRSA infections: finding it is not enough.
|
JAMA
|
2008
|
1.26
|
|
29
|
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.
|
Clin Infect Dis
|
2008
|
1.24
|
|
30
|
Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
|
J Clin Microbiol
|
2009
|
1.21
|
|
31
|
Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee.
|
Ann Intern Med
|
2013
|
1.16
|
|
32
|
Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates.
|
Fungal Genet Biol
|
2007
|
1.16
|
|
33
|
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
|
Antimicrob Agents Chemother
|
2008
|
1.11
|
|
34
|
To screen or not to screen for methicillin-resistant Staphylococcus aureus.
|
J Clin Microbiol
|
2010
|
1.11
|
|
35
|
Fluoroquinolone resistance in Streptococcus pyogenes.
|
Clin Infect Dis
|
2003
|
1.11
|
|
36
|
Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.
|
J Clin Microbiol
|
2008
|
1.10
|
|
37
|
Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention.
|
Infect Control Hosp Epidemiol
|
2012
|
1.10
|
|
38
|
Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?
|
Diagn Microbiol Infect Dis
|
2004
|
1.09
|
|
39
|
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
|
Diagn Microbiol Infect Dis
|
2010
|
1.06
|
|
40
|
Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.
|
Antimicrob Agents Chemother
|
2012
|
1.06
|
|
41
|
Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay.
|
J Clin Microbiol
|
2011
|
1.04
|
|
42
|
Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay.
|
J Clin Microbiol
|
2009
|
0.98
|
|
43
|
Nosocomial candidemia: an ounce of prevention is better than a pound of cure.
|
Infect Control Hosp Epidemiol
|
2004
|
0.98
|
|
44
|
Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.
|
J Clin Microbiol
|
2013
|
0.98
|
|
45
|
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
|
Diagn Microbiol Infect Dis
|
2006
|
0.97
|
|
46
|
Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois.
|
Eukaryot Cell
|
2008
|
0.97
|
|
47
|
Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.
|
J Clin Microbiol
|
2011
|
0.96
|
|
48
|
Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals.
|
Infect Control Hosp Epidemiol
|
2006
|
0.95
|
|
49
|
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
|
Diagn Microbiol Infect Dis
|
2009
|
0.95
|
|
50
|
Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.
|
Antimicrob Agents Chemother
|
2013
|
0.95
|
|
51
|
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.
|
Infect Control Hosp Epidemiol
|
2006
|
0.95
|
|
52
|
Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies.
|
Am J Obstet Gynecol
|
2009
|
0.95
|
|
53
|
In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.
|
Antimicrob Agents Chemother
|
2012
|
0.95
|
|
54
|
Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis.
|
Int J Med Microbiol
|
2009
|
0.95
|
|
55
|
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
|
Diagn Microbiol Infect Dis
|
2011
|
0.93
|
|
56
|
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
|
Antimicrob Agents Chemother
|
2011
|
0.93
|
|
57
|
Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit.
|
J Burn Care Res
|
2008
|
0.92
|
|
58
|
Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans.
|
Antimicrob Agents Chemother
|
2012
|
0.91
|
|
59
|
Ebola fever: reconciling planning with risk in U.S. hospitals.
|
Ann Intern Med
|
2014
|
0.91
|
|
60
|
Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.
|
J Clin Microbiol
|
2013
|
0.91
|
|
61
|
Methicillin-resistant Staphylococcus aureus in pork production shower facilities.
|
Appl Environ Microbiol
|
2010
|
0.90
|
|
62
|
Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
|
Diagn Microbiol Infect Dis
|
2010
|
0.90
|
|
63
|
Influenza vaccination rates, feedback and the Hawthorne effect.
|
Infect Control Hosp Epidemiol
|
2006
|
0.90
|
|
64
|
An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia.
|
Infect Control Hosp Epidemiol
|
2007
|
0.89
|
|
65
|
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
|
Diagn Microbiol Infect Dis
|
2009
|
0.89
|
|
66
|
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.
|
Antimicrob Resist Infect Control
|
2012
|
0.88
|
|
67
|
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
|
J Clin Microbiol
|
2007
|
0.87
|
|
68
|
Decline in invasive MRSA infection: where to go from here?
|
JAMA
|
2010
|
0.87
|
|
69
|
Survey of high school athletic programs in Iowa regarding infections and infection prevention policies and practices.
|
Iowa Orthop J
|
2013
|
0.87
|
|
70
|
Diagnosing and reporting of central line-associated bloodstream infections.
|
Infect Control Hosp Epidemiol
|
2012
|
0.86
|
|
71
|
Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States.
|
Diagn Microbiol Infect Dis
|
2011
|
0.85
|
|
72
|
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
|
J Clin Microbiol
|
2011
|
0.84
|
|
73
|
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
|
Antimicrob Agents Chemother
|
2011
|
0.83
|
|
74
|
The yeast connection: is Candida linked to breastfeeding associated pain?
|
Am J Obstet Gynecol
|
2007
|
0.83
|
|
75
|
Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.
|
Infect Control Hosp Epidemiol
|
2006
|
0.83
|
|
76
|
Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia.
|
Infect Control Hosp Epidemiol
|
2005
|
0.81
|
|
77
|
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
|
Diagn Microbiol Infect Dis
|
2013
|
0.80
|
|
78
|
Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals.
|
Infect Control Hosp Epidemiol
|
2005
|
0.80
|
|
79
|
Healthcare-associated fungal infections: beyond Candida and Aspergillus.
|
South Med J
|
2007
|
0.80
|
|
80
|
Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).
|
Emerg Infect Dis
|
2016
|
0.80
|
|
81
|
Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals.
|
Infect Control Hosp Epidemiol
|
2005
|
0.79
|
|
82
|
Alcohol-based hand gels and hand hygiene in hospitals.
|
Lancet
|
2002
|
0.78
|
|
83
|
Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae.
|
Pharmacotherapy
|
2003
|
0.75
|
|
84
|
Use of active surveillance cultures to control vancomycin-resistant Enterococcus.
|
Clin Infect Dis
|
2003
|
0.75
|
|
85
|
Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo.
|
Biochemistry
|
2015
|
0.75
|
|
86
|
Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus.
|
Obstet Gynecol
|
2008
|
0.75
|
|
87
|
Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
|
Int J Antimicrob Agents
|
2009
|
0.75
|
|
88
|
Prenatal testing for infectious disease.
|
Clin Lab Med
|
2003
|
0.75
|
|
89
|
Risk factors for groin wound infection after femoral artery catheterization: a case-control study.
|
Infect Control Hosp Epidemiol
|
2006
|
0.75
|
|
90
|
A case of recurrent episodes of Candida parapsilosis fungemia.
|
Mycopathologia
|
2006
|
0.75
|
|
91
|
Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship.
|
Ann Pharmacother
|
2012
|
0.75
|